Labcorp and Biogen Experts to Discuss Alzheimer's Diagnostic Data
As Alzheimer's disease diagnosis shifts from specialized clinics into primary care settings, the challenge of navigating evolving patient journeys has become a focal point for the healthcare sector. A new webinar aims to bridge this gap by examining how real-world laboratory data can accelerate patient access to treatment.
On July 9, 2026, industry leaders will convene to explore how high-fidelity diagnostic data translates into actionable clinical insights. The session, moderated by Dan Jacob of Labcorp, features a panel including Joseph Volpe, David Alfego, Wendy Webber Nelson, and Biogen’s Eli Shobin. The discussion will move beyond theoretical research, focusing on specific use cases that track how patients move through the healthcare system once neurological biomarkers are identified.
Beyond technical strategies, the event addresses the human element of clinical development. A patient advocacy perspective will be presented to illustrate how personal experiences shape collaborative frameworks, with a final call to action aimed at delivering faster answers to families. The webinar is designed for professionals in biopharma, clinical development, and patient advocacy who are managing the transition toward earlier, more accessible diagnostic evaluation.
Comments (0)
No comments yet. Be the first!